Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia.

Human beta-defensin-2 (hBD-2), a novel antimicrobial peptide, was originally isolated from human skin. We found that synthetic hBD-2 has high bactericidal activity against Escherichia coli under conditions nearly the same as in human bronchial airway surface liquid. We prepared an antiserum against hBD-2 and established a highly sensitive radioimmunoassay (RIA). Reverse-phase high-performance liquid chromatography coupled with the RIA showed that hBD-2 in patients with human lung, bronchoalveolar lavage flid, and plasma. The plasma concentration of hBD-2 in patients with bacterial pneumonia was 32.1 +/- 3.7 fmol/ml (mean +/- SE), 3.9-fold that of normal individuals. By reverse transcription-polymerase chain reaction, the hBD-2 gene transcript was detected in the respiratory epithelial surface of human lung. Human beta-defensin-2 seems to function in airway mucosal defense. Our findings provide a clue to elucidate its pathophysiological significance in respiratory infection.

[1]  M. Nakazato,et al.  Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. , 1998, The European respiratory journal.

[2]  M. Nakazato,et al.  Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[4]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[5]  R. Lehrer,et al.  Widespread expression of beta‐defensin hBD‐1 in human secretory glands and epithelial cells , 1996, FEBS letters.

[6]  T. Scanlin,et al.  Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha , 1996, Infection and immunity.

[7]  M. Raida,et al.  hBD‐1: a novel β‐defensin from human plasma , 1995 .

[8]  T. Ganz,et al.  Neutrophil defensins: purification, characterization, and antimicrobial testing. , 1994, Methods in enzymology.

[9]  M. Nakazato,et al.  Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. , 1993, Biochemical and biophysical research communications.

[10]  T. Ganz,et al.  In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins , 1990, Infection and immunity.

[11]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[12]  K. Kangawa,et al.  Molecular forms of atrial natriuretic polypeptides in mammalian tissues and plasma. , 1985, Biochemical and biophysical research communications.

[13]  N. Minamino,et al.  Regional distribution of adrenorphin in rat brain: comparative study with PH-8P. , 1984, Biochemical and biophysical research communications.